Personalis, Inc. (PSNL): Cash & Equivalents
$124.25M
As of 2025-12-31
$93.97M
As of 2026-06-30
+11.7%
3-year compound annual growth
+12.6%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $124.25M | +35.9% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $91.42M | +60.4% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $56.98M | -36.1% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $89.13M | -15.6% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $105.58M | +54.1% | 2024-02-28, Balance as of period end |
| 2020-12-31 | $68.53M | +24.5% | 2023-02-23, Balance as of period end |
| 2019-12-31 | $55.05M | +178.8% | 2022-02-24, Balance as of period end |
| 2018-12-31 | $19.74M | n/a | 2020-03-25, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Personalis, Inc. (PSNL) | 2025-12-31 | $124.25M | +35.9% |
| Exagen Inc. (XGN) | 2025-12-31 | $32.22M | +46.2% |
| Biodesix Inc (BDSX) | 2025-12-31 | $18.99M | -27.7% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $249.73M | +16.6% |
| CapForce Inc. (CFOR) | 2025-12-31 | $531.3K | -59.5% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $3.46M | -68.6% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $495.98M | +159.0% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $50.19M | -9.0% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $116.73M | -2.5% |
Compare PSNL, XGN, BDSX, GRAL side by side · Screen every company in Services-Medical Laboratories ↗